The Gross Margin of Halozyme Therapeutics Inc (HALO) is 84.30%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 84.30% |
| 2023-12-31 | 76.80% |
| 2022-12-31 | 78.90% |
| 2021-12-31 | 81.64% |
| 2020-12-31 | 83.78% |
| 2019-12-31 | 76.73% |
| 2018-12-31 | 93.29% |
| 2017-12-31 | 90.18% |
| 2016-12-31 | 77.37% |
| 2015-12-31 | 78.31% |